Compare SUVEN LIFE with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES ALEMBIC LTD SUVEN LIFESCIENCES/
ALEMBIC LTD
 
P/E (TTM) x 18.4 67.3 27.4% View Chart
P/BV x 3.7 2.4 156.2% View Chart
Dividend Yield % 0.6 0.4 132.4%  

Financials

 SUVEN LIFESCIENCES   ALEMBIC LTD
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ALEMBIC LTD
Mar-18
SUVEN LIFESCIENCES/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs33872 469.0%   
Low Rs16934 499.7%   
Sales per share (Unadj.) Rs52.14.7 1,109.0%  
Earnings per share (Unadj.) Rs6.86.1 111.9%  
Cash flow per share (Unadj.) Rs8.66.2 137.2%  
Dividends per share (Unadj.) Rs1.500.20 750.0%  
Dividend yield (eoy) %0.60.4 156.6%  
Book value per share (Unadj.) Rs65.340.7 160.6%  
Shares outstanding (eoy) m127.28267.03 47.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.911.3 43.2%   
Avg P/E ratio x37.18.7 427.9%  
P/CF ratio (eoy) x29.68.5 348.9%  
Price / Book Value ratio x3.91.3 298.2%  
Dividend payout %22.03.3 670.2%   
Avg Mkt Cap Rs m32,27214,139 228.2%   
No. of employees `0001.1NA-   
Total wages/salary Rs m661207 318.8%   
Avg. sales/employee Rs Th6,132.2NM-  
Avg. wages/employee Rs Th611.1NM-  
Avg. net profit/employee Rs Th803.5NM-  
INCOME DATA
Net Sales Rs m6,6351,255 528.6%  
Other income Rs m242370 65.4%   
Total revenues Rs m6,8771,625 423.1%   
Gross profit Rs m1,604111 1,443.9%  
Depreciation Rs m22138 585.7%   
Interest Rs m382 2,217.6%   
Profit before tax Rs m1,587442 359.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71824 2,997.9%   
Profit after tax Rs m8691,630 53.3%  
Gross profit margin %24.28.9 273.2%  
Effective tax rate %45.25.4 834.4%   
Net profit margin %13.1129.8 10.1%  
BALANCE SHEET DATA
Current assets Rs m6,2321,867 333.8%   
Current liabilities Rs m1,490591 252.0%   
Net working cap to sales %71.5101.6 70.3%  
Current ratio x4.23.2 132.4%  
Inventory Days Days8694 91.7%  
Debtors Days Days8374 112.3%  
Net fixed assets Rs m4,0431,791 225.8%   
Share capital Rs m127534 23.8%   
"Free" reserves Rs m8,18310,324 79.3%   
Net worth Rs m8,31010,858 76.5%   
Long term debt Rs m1841 43.2%   
Total assets Rs m10,38911,591 89.6%  
Interest coverage x43.1260.9 16.5%   
Debt to equity ratio x00 56.5%  
Sales to assets ratio x0.60.1 589.7%   
Return on assets %8.714.1 62.0%  
Return on equity %10.515.0 69.7%  
Return on capital %19.515.2 128.5%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m5,62219 28,978.2%   
Fx outflow Rs m1,799264 682.1%   
Net fx Rs m3,822-244 -1,563.8%   
CASH FLOW
From Operations Rs m356236 150.8%  
From Investments Rs m-279-224 124.4%  
From Financial Activity Rs m-225-27 846.2%  
Net Cashflow Rs m-148-15 1,001.4%  

Share Holding

Indian Promoters % 63.4 64.0 99.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 0.0 9.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 26.1 139.8%  
Shareholders   37,287 54,701 68.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   AJANTA PHARMA  GLENMARK PHARMA  ORCHID PHARMA LTD  STRIDES PHARMA SCIENCE  FDC LTD.  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 292 Points Higher; Automobile and Metal Stocks Witness Buying(Closing)

After opening the day marginally higher, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 15, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS